LPCUF (Lee's Pharmaceutical Holdings) FCF Margin % : -0.49% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lee's Pharmaceutical Holdings's Free Cash Flow for the six months ended in Jun. 2024 was $-0.4 Mil. Lee's Pharmaceutical Holdings's Revenue for the six months ended in Jun. 2024 was $84.3 Mil. Therefore, Lee's Pharmaceutical Holdings's FCF Margin % for the quarter that ended in Jun. 2024 was -0.49%.

As of today, Lee's Pharmaceutical Holdings's current FCF Yield % is -0.63%.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's FCF Margin % or its related term are showing as below:

LPCUF' s FCF Margin % Range Over the Past 10 Years
Min: -12.64 Med: 2.29 Max: 13.43
Current: -0.37

During the past 13 years, the highest FCF Margin % of Lee's Pharmaceutical Holdings was 13.43%. The lowest was -12.64%. And the median was 2.29%.

LPCUF's FCF Margin % is ranked worse than
55.17% of 977 companies
in the Drug Manufacturers industry
Industry Median: 0.87 vs LPCUF: -0.37

Lee's Pharmaceutical Holdings FCF Margin % Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings FCF Margin % Chart

Lee's Pharmaceutical Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-11.44

-12.64

5.66

-4.71

Lee's Pharmaceutical Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-14.62	-9.29	-0.38	-0.49	-

Competitive Comparison of Lee's Pharmaceutical Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lee's Pharmaceutical Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Lee's Pharmaceutical Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lee's Pharmaceutical Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-6.355	/	134.835
	=	-4.71 %

Lee's Pharmaceutical Holdings's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-0.409	/	84.295
	=	-0.49 %

Lee's Pharmaceutical Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lee's Pharmaceutical Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » FCF Margin %

Traded in Other Exchanges

00950:Hong Kong

Address

Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG

Website

https://www.leespharm.com

Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines